SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Asim A. Shah, Imran S. Khawaja, Awais Aftab, Are Psychotropic Drugs Safe to Use During Pregnancy?, Psychiatric Annals, 2015, 45, 2, 71

    CrossRef

  2. You have free access to this content2
    Blanca Arguello, Teresa M. Salgado, Fernando Fernandez-Llimos, Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation, British Journal of Clinical Pharmacology, 2015, 79, 3
  3. 3
    Sarah C. Tinker, Suzanne Gilboa, Jennita Reefhuis, Mary M. Jenkins, Marcy Schaeffer, Cynthia A. Moore, Challenges in Studying Modifiable Risk Factors for Birth Defects, Current Epidemiology Reports, 2015, 2, 1, 23

    CrossRef

  4. 4
    Doreen Matsui, Ethics of Studies of Drugs in Pregnancy, Pediatric Drugs, 2015, 17, 1, 31

    CrossRef

  5. 5
    Michele L. Okun, Rebecca Ebert, Bandana Saini, A review of sleep-promoting medications used in pregnancy, American Journal of Obstetrics and Gynecology, 2014,

    CrossRef

  6. 6
    J. S. Sheffield, D. Siegel, M. Mirochnick, R. P. Heine, C. Nguyen, K. L. Bergman, R. M. Savic, J. Long, K. E. Dooley, M. Nesin, Designing Drug Trials: Considerations for Pregnant Women, Clinical Infectious Diseases, 2014, 59, suppl 7, S437

    CrossRef

  7. 7
    Cheryl S. Broussard, Meghan T. Frey, Sonia Hernandez-Diaz, Michael F. Greene, Christina D. Chambers, Leyla Sahin, Beth A. Collins Sharp, Margaret A. Honein, Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention–convened meeting, American Journal of Obstetrics and Gynecology, 2014, 211, 3, 208

    CrossRef

  8. 8
    M. M. H. J. van Gelder, J. H. J. Bos, N. Roeleveld, L. T. W. de Jong-van den Berg, Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009, Human Reproduction, 2014, 29, 1, 161

    CrossRef

  9. 9
    M. M. H. J. van Gelder, L. T. W. de Jong-van den Berg, N. Roeleveld, Drugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risks, Human Reproduction, 2014, 29, 1, 168

    CrossRef

  10. 10
    Natan de David, Mariana de Oliveira Mauro, Caroline Amélia Gonçalves, João Renato Pesarini, Regiane Lauriano Batista Strapasson, Cândida Aparecida Leite Kassuya, Maria Élida Alves Stefanello, Andréa Luiza Cunha-Laura, Antônio Carlos Duenhas Monreal, Rodrigo Juliano Oliveira, Gochnatia polymorpha ssp. floccosa: Bioprospecting of an anti-inflammatory phytotherapy for use during pregnancy, Journal of Ethnopharmacology, 2014, 154, 2, 370

    CrossRef

  11. 11
    Sarah C. Tinker, Cheryl S. Broussard, Meghan T. Frey, Suzanne M. Gilboa, Prevalence of Prescription Medication Use Among Non-pregnant Women of Childbearing Age and Pregnant Women in the United States: NHANES, 1999–2006, Maternal and Child Health Journal, 2014,

    CrossRef

  12. 12
    Axel Wiebrecht, Wilhelm Gaus, Simon Becker, Josef Hummelsberger, Kirsten Kuhlmann, Safety aspects of Chinese herbal medicine in pregnancy—Re-evaluation of experimental data of two animal studies and the clinical experience, Complementary Therapies in Medicine, 2014, 22, 5, 954

    CrossRef

  13. 13
    Marleen M.H.J. van Gelder, Iris A.L.M. van Rooij, Lolkje T.W. de Jong-van den Berg, Nel Roeleveld, Teratogenic Mechanisms Associated with Prenatal Medication Exposure, Thérapie, 2014, 69, 1, 13

    CrossRef

  14. 14
    Michiel F Schreuder, Ruud R G Bueters, Karel Allegaert, The interplay between drugs and the kidney in premature neonates, Pediatric Nephrology, 2014, 29, 11, 2083

    CrossRef

  15. 15
    Maryann Mazer-Amirshahi, Samira Samiee-Zafarghandy, George Gray, Johannes N. van den Anker, Trends in pregnancy labeling and data quality for US-approved pharmaceuticals, American Journal of Obstetrics and Gynecology, 2014, 211, 6, 690.e1

    CrossRef

  16. 16
    Sonja A. Rasmussen, Amelia K. Watson, Erin D. Kennedy, Karen R. Broder, Denise J. Jamieson, Vaccines and pregnancy: Past, present, and future, Seminars in Fetal and Neonatal Medicine, 2014, 19, 3, 161

    CrossRef

  17. 17
    Kristine E. Shields, Anne Drapkin Lyerly, Exclusion of Pregnant Women From Industry-Sponsored Clinical Trials, Obstetrics & Gynecology, 2013, 122, 5, 1077

    CrossRef

  18. 18
    Marleen M. H. J. van Gelder, Iris A. L. M. van Rooij, Hermien E. K. de Walle, Nel Roeleveld, Marian K. Bakker, Maternal Recall of Prescription Medication Use During Pregnancy Using a Paper-Based Questionnaire, Drug Safety, 2013, 36, 1, 43

    CrossRef

  19. 19
    Phoebe G. Thorpe, Suzanne M. Gilboa, Sonia Hernandez-Diaz, Jennifer Lind, Janet D. Cragan, Gerald Briggs, Sandra Kweder, Jan M. Friedman, Allen A. Mitchell, Margaret A. Honein, Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk, Pharmacoepidemiology and Drug Safety, 2013, 22, 9
  20. 20
    Karin E. Johnson, Sarah J. Beaton, Susan E. Andrade, T. Craig Cheetham, Pamela E. Scott, Tarek A. Hammad, Inna Dashevsky, William O. Cooper, Robert L. Davis, Pamala A. Pawloski, Marsha A. Raebel, David H. Smith, Sengwee Toh, De-Kun Li, Katherine Haffenreffer, Sascha Dublin, Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes, Pharmacoepidemiology and Drug Safety, 2013, 22, 7
  21. 21
    Richard H. Beigi, Lisa Noguchi, Gina Brown, Jeanna Piper, D. Heather Watts, Performing Drug Safety Research During Pregnancy and Lactation: Biomedical HIV Prevention Research as a Template, Journal of Women's Health, 2013, 150127063144003

    CrossRef

  22. 22
    Stephanie Dellicour, Philippe Brasseur, Per Thorn, Oumar Gaye, Piero Olliaro, Malik Badiane, Andy Stergachis, Feiko O. ter Kuile, Probabilistic Record Linkage for Monitoring the Safety of Artemisinin-Based Combination Therapy in the First Trimester of Pregnancy in Senegal, Drug Safety, 2013, 36, 7, 505

    CrossRef

  23. 23
    Stacey L. Peters, Jennifer N. Lind, Jasmine R. Humphrey, Jan M. Friedman, Margaret A. Honein, Melissa S. Tassinari, Cynthia A. Moore, Lisa L. Mathis, Cheryl S. Broussard, Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011, Pharmacoepidemiology and Drug Safety, 2013, 22, 3
  24. 24
    Margaret A Honein, Suzanne M Gilboa, Cheryl S Broussard, The need for safer medication use in pregnancy, Expert Review of Clinical Pharmacology, 2013, 6, 5, 453

    CrossRef

  25. 25
    Toby Schonfeld, The perils of protection: vulnerability and women in clinical research, Theoretical Medicine and Bioethics, 2013, 34, 3, 189

    CrossRef

  26. 26
    Sara E. Rosenquist, When the Bough Breaks: Rethinking Treatment Strategies for Perinatal Depression, American Journal of Clinical Hypnosis, 2013, 55, 3, 291

    CrossRef

  27. 27
    Jan M. Friedman, James W. Hanson, Emery and Rimoin's Principles and Practice of Medical Genetics, 2013,

    CrossRef

  28. 28
    Donald R. Mattison, Clinical Pharmacology During Pregnancy, 2013,

    CrossRef

  29. 29
    Jan M. Friedman, ABCDXXX: The obscenity of postmarketing surveillance for teratogenic effects, Birth Defects Research Part A: Clinical and Molecular Teratology, 2012, 94, 8
  30. 30
    Ahmed H. Al-jedai, Sakra S. Balhareth, Roaa A. Algain, Assessment of foetal risk associated with 93 non-US-FDA approved medications during pregnancy, Saudi Pharmaceutical Journal, 2012, 20, 4, 287

    CrossRef

  31. 31
    Sonja A. Rasmussen, Human teratogens update 2011: Can we ensure safety during pregnancy?, Birth Defects Research Part A: Clinical and Molecular Teratology, 2012, 94, 3
  32. 32
    Sonja A. Rasmussen, Michael L. Power, Denise J. Jamieson, Jennifer Williams, Jay Schulkin, Emily B. Kahn, Yujia Zhang, Kitty MacFarlane, Dmitry M. Kissin, Practices of obstetrician-gynecologists regarding nonvaccine-related public health recommendations during the 2009 H1N1 influenza pandemic, American Journal of Obstetrics and Gynecology, 2012, 207, 4, 294.e1

    CrossRef

  33. 33
    Marion Tegethoff, Naomi Greene, Jørn Olsen, Emmanuel Schaffner, Gunther Meinlschmidt, Reply, American Journal of Respiratory and Critical Care Medicine, 2012, 185, 12, 1327

    CrossRef

  34. 34
    Susan Blackburn, Internet Resources, The Journal of Perinatal & Neonatal Nursing, 2011, 25, 4, 310

    CrossRef

  35. 35
    Melissa A. Parisi, Catherine Y. Spong, Anne Zajicek, Alan E. Guttmacher, We don't know what we don't study: The case for research on medication effects in pregnancy, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011, 157, 3